Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 15

1.

Metal Template Assisted Proximal Arrangement of a Nucleophile and an Electrophile: Site-Selective Acylation of α-Hydroxyamides in Polyols.

Nishikawa Y, Takemoto K, Matsuda K, Tanaka R, Arashima A, Ito K, Kamezawa Y, Hori Y, Hara O.

Org Lett. 2018 Jun 1;20(11):3367-3371. doi: 10.1021/acs.orglett.8b01288. Epub 2018 May 23.

PMID:
29790765
2.

Osteopontin transgenic mice fed a high-cholesterol diet develop early fatty-streak lesions.

Isoda K, Kamezawa Y, Ayaori M, Kusuhara M, Tada N, Ohsuzu F.

Circulation. 2003 Feb 11;107(5):679-81.

PMID:
12578867
3.

Osteopontin plays an important role in the development of medial thickening and neointimal formation.

Isoda K, Nishikawa K, Kamezawa Y, Yoshida M, Kusuhara M, Moroi M, Tada N, Ohsuzu F.

Circ Res. 2002 Jul 12;91(1):77-82.

PMID:
12114325
4.

Myocardial hypertrophy in transgenic mice overexpressing human interleukin 1alpha.

Isoda K, Kamezawa Y, Tada N, Sato M, Ohsuzu F.

J Card Fail. 2001 Dec;7(4):355-64.

PMID:
11782860
5.

Effect of coronary risk factors on arterial compensatory enlargement in japanese middle-aged patients with de novo single-vessel disease--an intravascular ultrasound study.

Isoda K, Arakawa K, Kamezawa Y, Nishizawa K, Nishikawa K, Shibuya T, Ohsuzu F, Nakamura H.

Clin Cardiol. 2001 Jun;24(6):443-50.

6.
7.

Streptococcal mitogenic exotoxin Z, a novel acidic superantigenic toxin produced by a T1 strain of Streptococcus pyogenes.

Kamezawa Y, Nakahara T, Nakano S, Abe Y, Nozaki-Renard J, Isono T.

Infect Immun. 1997 Sep;65(9):3828-33.

8.

A case of acute massive pulmonary thromboembolism treated by mechanical clot fragmentation using a percutaneous transluminal angioplasty balloon.

Isoda K, Satomura K, Hamabe A, Hagisawa K, Kamezawa Y, Sugiyabu Y, Kurita A, Nakamura H.

Jpn Circ J. 1997 Jun;61(6):531-5.

9.

In vitro glucuronidation of 25-hydroxyvitamin D3 and its pro-form.

Shimada K, Kamezawa Y, Mitamura K.

Biol Pharm Bull. 1997 Jun;20(6):596-600.

PMID:
9212974
10.

Nonneutralizing antibody to erythrogenic toxin A alpha(NY5ETA) in human sera.

Nakano S, Abe Y, Kamezawa Y, Nakahara T.

Adv Exp Med Biol. 1997;418:923-4.

PMID:
9331800
11.

A new exocellular mitogen from NY5 strain Streptococcus pyogenes antigenically different from erythrogenic toxins A, B, and C.

Kamezawa Y, Nakahara T, Nakano S, Abe Y.

Adv Exp Med Biol. 1997;418:571-6. No abstract available.

PMID:
9331716
12.

Physicochemical separation of A beta subtype from A alpha type erythrogenic toxin produced by T1 strain Streptococcus pyogenes.

Kamezawa Y, Nakahara T, Nakano S, Abe Y.

Adv Exp Med Biol. 1997;418:567-70. No abstract available.

PMID:
9331715
13.

Increased vascular permeability, erythema, and leukocyte emigration induced in rabbit skin by streptococcal erythrogenic toxin type A.

Kamezawa Y, Nakahara T, Abe Y, Kato I.

FEMS Microbiol Lett. 1990 Mar 1;56(1-2):159-62.

PMID:
2185123
14.

Detection of serum antibody by the antimitogen assay against streptococcal erythrogenic toxins. Age distribution in children and the relation to Kawasaki disease.

Abe Y, Nakano S, Nakahara T, Kamezawa Y, Kato I, Ushijima H, Yoshino K, Ito S, Noma S, Okitsu S, et al.

Pediatr Res. 1990 Jan;27(1):11-5.

PMID:
2404253

Supplemental Content

Loading ...
Support Center